Akso Health (AHG) Receivables - Other (2017 - 2026)

Akso Health (AHG) has reported Receivables - Other for 8 consecutive years, with $184.8 million the latest figure, recorded in Q1 2026.

• Quarterly Receivables - Other fell 8.82% year-over-year to $184.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $184.8 million (down 8.82% YoY) and the FY2026 annual result came in at $184.8 million, down 8.82% from the prior year.
• Receivables - Other fell to $184.8 million in Q1 2026 per AHG's latest filing, from $202.6 million in the prior quarter.
• Over the last five years, Receivables - Other for AHG reached as high as $202.6 million in Q1 2025 and fell as low as $20.0 million in Q1 2022.
• A 4-year average of $91.8 million and a median of $26.2 million in 2023 frame the typical range for Receivables - Other.
• Annual changes were most pronounced in 2022 — Receivables - Other soared 463.1% — and 2026, when it dropped 8.82%.
• Year by year, Receivables - Other stood at $25.4 million in 2022, then gained by 3.33% to $26.2 million in 2023, then soared by 673.2% to $202.6 million in 2025, then dropped by 8.82% to $184.8 million in 2026.
• According to Business Quant data, Receivables - Other over the past three periods registered $184.8 million, $202.6 million, and $26.2 million for Q1 2026, Q1 2025, and Q1 2023 respectively.